In this interview, we spoke with Amy Peterson, EVP & Chief Development Officer at CytomX Therapeutics ahead of her talk on Day 1 of the Undruggable Leaders Forum in September 2021. Amy shared her insights into the most exciting and challenging areas in the industry, CytomX’s approach to the undruggable, and much much more.
Topics covered include:
- What are the biggest challenges facing ‘undruggable’ today?
- What is the main limiting factor with therapeutic antibodies and how are CytomX working to overcome this?
- What do the next 5 years look like for CytomX and what developments would you like to see across the industry?